NewsEvents

Your Yourlocation: Home > To evaluate the efficacy of tiotropium bromide(136310-93-5) combined with continuous low-flow oxygen therapy in patients with chronic obstructive pulmonary disease

Analysis of the efficacy of tiotropium bromide(136310-93-5) combined with continuous low-flow oxygen therapy for chronic stable lung disease showed that tiotropium combined with continuous low-dose oxygen therapy significantly improved lung function and exercise capacity in stable COPD patients. The article published on "clinical medicine literature electronic magazine".

The aim of this study was to observe the efficacy of inhaled tiotropium bromide(136310-93-5) in combination with continuous low-flow oxygen therapy for stable chronic obstructive pulmonary disease (COPD).

METHODS: Sixty-eight patients were randomized to receive tiotropium bromide(136310-93-5) inhalation combined with low-dose oxygen inhalation and albuterol inhalation with low-dose oxygen in the control group. After 3 months of treatment, the lung function and exercise capacity of the two groups were compared before and after treatment.

The results showed that the two groups of patients with lung function, exercise capacity than before to improve the treatment group and the control group, the difference was statistically significant (P <0.05).

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved